(Q53325995)

13 May 2018

title

Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated processes. (English)

1 reference

13 May 2018

1 reference

McIntosh LJ

1

1 reference

13 May 2018

Trush MA

series ordinal

2

1 reference

13 May 2018

Troncoso JC

series ordinal

3

1 reference

13 May 2018

publication date

1 January 1997

1 reference

13 May 2018

Free Radical Biology and Medicine

published in

1 reference

13 May 2018

volume

23

1 reference

13 May 2018

page(s)

183-190

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Mitochondria from Alzheimer's fibroblasts show decreased uptake of calcium and increased sensitivity to free radicals.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Alzheimer skin fibroblasts show increased susceptibility to free radicals.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Brain membrane fluidity and lipid peroxidation in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Are reactive oxygen species involved in Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Aging, energy, and oxidative stress in neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Activation of macrophages by Alzheimer beta amyloid peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Electron transport chain defects in Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Analyses of energy metabolism and mitochondrial genome in post-mortem brain from patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Microsomal lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Evidence of an oxidative challenge in the Alzheimer's brain

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Superoxide dismutase isoenzymes in normal brains and in brains from patients with dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Copper-zinc superoxide dismutase activity in red blood cells in probable Alzheimer's patients and their first-degree relatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer's disease: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Cerebrospinal fluid ferritin levels of patients with Parkinson's disease, Alzheimer's disease, and multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Brain iron and ferritin in Parkinson's and Alzheimer's diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Content and fatty acid composition of cardiolipin in the brain of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II).

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Evidence for a membrane defect in Alzheimer disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Elevation in relative levels of brain membrane unsaturated fatty acids in Alzheimer's disease: high resolution proton spectroscopic studies of membrane lipid extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Lipid peroxidation and free radical scavengers in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Vitamin E concentrations in human brain of patients with Alzheimer's disease, fetuses with Down's syndrome, centenarians, and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

Concentrations of alpha-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2896%2900573-4

7 January 2021

10.1016/S0891-5849(96)00573-4

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

9199880

1 reference

13 May 2018